Integrated analyses of an RNA binding protein-based signature related to tumor immune microenvironment and candidate drugs in osteosarcoma

CONCLUSION: We evaluated the prognostic value and clinical application of an RBPs-based prognostic signature and identified promising biomarkers to predict immune cell infiltration and immunotherapy response in osteosarcoma.PMID:35559393 | PMC:PMC9091083

Source: American Journal of Translational Research - May 13, 2022 Category: Research Authors: Abdulraheem Gul Mohammad Dapeng Li Rong He Xuan Lei Lianghao Mao Bing Zhang Xinyu Zhong Zhengyu Yin Wenbing Cao Wenchao Zhang Ruoxuan Hei Qiping Zheng Yiming Zhang Source Type: research